Status:
WITHDRAWN
Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Intravenous Drug Abuse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People who inject drugs (PWID) experience high risk of HIV acquisition. Antiretroviral pre-exposure prophylaxis (PrEP) is an efficacious biomedical HIV prevention strategy for high risk HIV-uninfected...
Detailed Description
This mixed methods phased research will use qualitative and quantitative techniques to improve PrEP uptake and adherence among PWID through the following three phases: * Phase 1 will identify the mod...
Eligibility Criteria
Inclusion
- For all phases:
- An adult PWID
- Self report of any high risk behaviors for HIV (past-month receptive syringe sharing, transactional sex, condomless sex with an HIV-infected or unknown status partner)
Exclusion
- Unable or unwilling to provide informed consent
- For Phase 3 (the RCT pilot):
- Inclusion Criteria:
- Clinically eligible for PrEP (confirmed HIV-uninfected status, adequate renal function \[estimated creatinine clearance ≥60 ml/min\], and documented hepatitis B virus \[HBV\] status)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03869671
Start Date
March 1 2021
End Date
March 1 2022
Last Update
March 10 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.